Turf War Exposes Big Pharma's Dark Side as Bayer Sues Vaccine Makers** In a shocking twist in the battle for pharmaceutical profits, Bayer has launched lawsuits against giants P ...

Parabilis Medicines raised $305 million in a Series F round led by RA Capital, Fidelity and Janus Henderson, with crossover ...

For over 60 years, the search for an effective pharmacologic treatment for refractory or unexplained chronic cough has been ...

For pregnant women who received the bivalent prefusion F subunit-based respiratory syncytial virus (RSV) vaccine (RSVpreF; ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an upda ...

Researchers found that in mouse models (in a lab), SARS‑CoV‑2 mRNA vaccination triggered strong type I interferon signals, ...

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

The government’s announcement that GC Biopharma was selected as a Phase 1 (first-stage clinical trial) support company for an ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Your decision on whether to invest now depends to some extent on your investment strategy. During earlier pandemic days, Moderna and rival Pfizer saw sales of their vaccines explode higher. In the ...

Detailed price information for GT Biopharma Inc (GTBP-Q) from The Globe and Mail including charting and trades.